Table 2. Visual Analog Scale and Kujala Patellofemoral Scale scores of the groups before the treatment and at week 6 and week 12.
Group 1 | Group 2 | Group 3 | ||||||
Median | Min-Max | Median | Min-Max | Median | Min-Max | c2 | p | |
Visual Analog Scale | 0,452 | |||||||
(0-100 mm) | ||||||||
Before treatment | 40 | 20-70 | 50 | 30-80 | 50 | 20-80 | 0,726 | |
6th week | 30 | 0-50 | 20 | 0-40 | 20 | 0-40 | - | |
12th week | 40 | 0-60 | 30 | 0-60 | 30 | 10-50 | - | |
Kujala Patellofemoral Scale | 0,701 | |||||||
(0-100) | ||||||||
Before treatment | 84 | 70-91 | 85 | 72-96 | 84 | 67-91 | 0,587 | |
6th week | 87 | 74-100 | 89 | 81-100 | 87 | 82-94 | - | |
12th week | 87 | 74-96 | 88 | 76-98 | 86 | 76-92 | - | |
Min: Minimum; Max: Maximum; Change 1: Before treatment - 6th week; Change 2: Before treatment - 12th week. |